Pharmacology of Nitrosourea Anticancer Agents

  • Ann L. Wang
  • Philip S. Schein
Part of the Developments in Oncology book series (DION, volume 23)


In 1959, 1-methyl-1-nitroso-3-nitroguanidine (MNNG) was reported to have a measurable and reproducible antitumor activity against the murine ascitic leukemia, L1210 (1). This observation resulted in extensive study of the N-nitroso compounds of antitumor activity. It was demonstrated that the nitroso group was required for activity and that substitution of a chloroethyl on the terminal methyl group enhanced antitumor activity. This led to the development of l-(2-chloroethyl)-nitrosourea (2).


Hydrocortisone Myeloma Isocyanate Streptozotocin BCNU 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Greene M. O., Greenberg J.: The activity of nitrosoguanidines against ascites tumors in mice. Cancer Res (20): 1166–1173, 1960.PubMedGoogle Scholar
  2. 2.
    Hyde K. A., Acton E., Skinner W. A., Goodman L., Greenberg J., Baker B. R.: Potential anticancer agents. LXII. The relationship of chemical structure to antileukemic adults with analogs of 1-methyl-3-nitroguanidine (NSC-9369). J Med Pharm Chem (5): 1–14, 1962.CrossRefGoogle Scholar
  3. 3.
    Skipper H. E., Schabel F. M., Trader M. W., Thomson J. R.: Experimental evaluation of potential anticancer agents. VI. Anatomical distribution of leukemic cells and failure of chemotherapy. Cancer Res (21): 1154–1164, 1961.PubMedGoogle Scholar
  4. 4.
    Johnston T. P., McCaleb G. S., Montgomery J. A.: The synthesis of antineoplastic agents, XXXII. N-nitrosoureas. Int J Med Chem 6: 669–681, 1963.CrossRefGoogle Scholar
  5. 5.
    Wasserman T. H., Slavic M., Carter S. K.: Clinical comparison of the nitrosoureas. Cancer (36): 1258–1268, 1975.PubMedCrossRefGoogle Scholar
  6. 6.
    Rakieten N., Rakieten M., Nadkarni M.: Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep (29): 91–98, 1963.Google Scholar
  7. 7.
    Johnston T. P., McCaleb G. G., Montgomery J. A.: The synthesis of chlorozotocin, the 2-chloroethyl analoaue of the anticancer antibiotic streptozotocin. J Med Chem (18): 104–106, 1975.PubMedCrossRefGoogle Scholar
  8. 8.
    Colvin M., Brundhett R. B., Cowens W., Jardin I., Ludlum D.: A chemical basis for the antitumor activity of chloroethylnitrosoureas. Biochem Pharmacol (25): 695–699, 1976.PubMedCrossRefGoogle Scholar
  9. 9.
    Montgomery J. A., James R., McCaleb G. S., Kirk M. C., Johnston T. P.: Decomposition of N-(2-chloroethyl)-N-nitrosourea in aqueous media. J Med Chem (18): 568–571, 1975.PubMedCrossRefGoogle Scholar
  10. 10.
    Schein P. S.: Nitrosourea antitumor agents. In: Advances in Cancer Chemotherapy ( Umezawa H, ed) Baltimore, University Park Press, 1978 pp 95–106.Google Scholar
  11. 11.
    Montgomery J. A., James R., McCaleb G. S., Johnston T. P.: The modes of decomposition of l,3-bis(2-chloroethyl)-l-nitrosourea and related compounds. J Med Chem (10): 668–674, 1967.PubMedCrossRefGoogle Scholar
  12. 12.
    Wheeler G. P., Bowdon B. J., Struck R. T.: Carbamoylation of amino acids, peptides and proteins by nitrosoureas. Cancer Res (35): 2974–2994, 1975.PubMedGoogle Scholar
  13. 13.
    Panasci L. C., Green D., Nagourney R., Fox P., Schein P. S.: A structure-activity analysis of chemical and biological parameters of chlorethylnitrosoureas in mice. Cancer Res (37): 2615–2618, 1977.PubMedGoogle Scholar
  14. 14.
    Heal J. M., Fox P., Schein P. S.: A structure-activity study of seven new water soluble nitrosoureas. Biochem Pharmacol (28): 1301–1306, 1979.PubMedCrossRefGoogle Scholar
  15. 15.
    Kohn K. W.: Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-l- nitrosourea and other l-(2-haloethyl)-l-nitrosourea. Cancer Res 37: 1450–1454 1977.PubMedGoogle Scholar
  16. 16.
    Bray D. A., DeVita V. T., Adamson R. H., Oliverio V. T.: Effects of l-(2-chloroethyl)-3 cyclohexyl-1-ni trosourea (CCNU NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle. Cancer Chemother Rep (55): 215–220, 1971.Google Scholar
  17. 17.
    Kann H. E., Kohn K. W., Lyles J. M.: Inhibition of DNA repair by the 1,3-bis(2- chloroethyl)-1-nitrosourea breakdown product, 2-chloroethyl isocyanate. Cancer Res (34): 398–402, 1974.PubMedGoogle Scholar
  18. 18.
    Baril B. E., Baril E. F., Laszlo J., Wheeler G. P.: Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates. Cancer Res (35): 1–5, 1975.PubMedGoogle Scholar
  19. 19.
    Babson J. R., Reed D. J.: Inactivation of glutathione reductase by 2-chloroethyl nitrosourea-derived isocyanates. Biochem Biophys Res comm (83): 754–762, 1978.PubMedCrossRefGoogle Scholar
  20. 20.
    Tew K. D., Sudhakar S., Schein P. S., Smulson M. E.: Binding of chlorozotocin and l-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to chromatin and nucleosomal fractions of HeLa cells. Cancer Res (38): 3371–3378, 1978.PubMedGoogle Scholar
  21. 21.
    Kann H. E., Kohn K. W., Widerlite L., Gullion A.: Effects of 1,3-bis(2-chloroethyl) -1-nitrosourea and related compounds on nuclear RNA metabolism. Cancer Res (37): 1450–1454, 1977.Google Scholar
  22. 22.
    Frischer H., Ahmad T.: Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU (1,3-bis(chloroethyl)-1- nitrosourea).Google Scholar
  23. 23.
    Tew K. D., Wang A. L.: Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards. Mol Pharm (21): 729–738, 1982.Google Scholar
  24. 24.
    Wang A. L., Tew K. D.: Carbamoylation of glutathione reductase as a toxic property of nitrosoureas in an alkylating agent resistant cell lines. Submitted.Google Scholar
  25. 25.
    Thomas J. O., Kornberg R. D.: An octamer of hi stones in chromatin and free in solution. Proc Nat Acad Sci USA (72): 2626–2630, 1975.PubMedCrossRefGoogle Scholar
  26. 26.
    Garel A., Axel R.: Selective digestion of transcriptionally active ovalbumin gene for oviduct nuclei. Proc Nat Acad Sci USA 73: 3966–3970, 1976.PubMedCrossRefGoogle Scholar
  27. 27.
    Tew K. D., Schein P. S., Lindner D. J., Wang A. L., Smulson M. E.: Hydrocortisone modification of chromatin structure alters nitrosourea binding within the nucleus. Cancer Res (40): 3697–3703, 1980.PubMedGoogle Scholar
  28. 28.
    Byrne P., Tew K., Jemionek J., MacVittie T., Erickson L., Schein, P. S.: Cellular and molecular mechanisms of bone marrow sparing effects of the glucose chloroethylnitrosourea chlorozotocin. Blood: In press.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • Ann L. Wang
  • Philip S. Schein

There are no affiliations available

Personalised recommendations